Eli Lilly’s trial weight-loss drug reduces heart failure risk by 38%
Eli Lilly and Company’s Zepbound or trizepatide injection to treat obesity reduces the risk of heart failure, hospitalisation and cardiovascular death by 38%,
Eli Lilly and Company’s Zepbound or trizepatide injection to treat obesity reduces the risk of heart failure, hospitalisation and cardiovascular death by 38%,
The US Food and Drug Administration has approved the Darzalex Faspro combination drug therapy of Janssen Research and Development for treating blood cancer.
HQ Team July 31, 2024: A new research published in the Annals of Internal Medicine reveals that semaglutide is effective in helping people quit
A survey from the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) shows that nearly a third of American adolescents and teens received
An eye scan can spot early signs of Alzheimer’s disease in the retina or the small blood vessels in the back of the
The SARS-CoV-2 virus was detected in six backyard species in the southeastern US state of Virginia with unique viral mutations with lineages closely
About 24% of adolescent girls or close to 19 million globally have experienced physical or sexual violence by their intimate partner by the
Daiichi Sankyo and AstraZeneca’s breast cancer treatment ran into opposition from the UK’s healthcare spending watchdog, which wants Enhertu drug to be offered
Overdose of weight-loss drugs and dosing errors by patients and healthcare providers have led to adverse events, including hospitalisation, the USFDA warned.
Argentina’s Sinergium Biotech will share its technology and expertise to manufacture bird flu vaccine with partners in low and middle-income countries in case